Shared on03 Oct 25Fair value Increased 4.83%
Adient’s analyst price target has increased from $26.91 to $28.21. This reflects improved expectations for revenue growth and margin expansion, as analysts highlight ongoing cost progress, stronger contract terms, and potential benefits from geographic market shifts and restructuring efforts.
Shared on08 Aug 25Fair value Increased 9.61%
The price target for Adient has been raised to $26.10, reflecting improved revenue growth forecasts and a lower forward P/E multiple. What's in the News Adient launched an innovative mechanical massage seat system, first featured in GAC-Trumpchi's new PHEV M8, offering industry-first comfort and safety features.
Shared on31 Jul 25
With both the discount rate and future P/E metrics remaining essentially stable, there has been no material change to Adient's consensus analyst price target, which holds steady at $24.55. What's in the News Adient launched an industry-first mechanical massage seat solution, debuting in GAC-Trumpchi's new M8 PHEV, with mass production underway and global customer interest.
Shared on23 Apr 25Fair value Decreased 2.21%
AnalystConsensusTarget has decreased revenue growth from 0.1% to 0.0%.
Shared on17 Apr 25Fair value Decreased 6.21%
AnalystConsensusTarget has decreased revenue growth from 0.2% to 0.1% and decreased future PE multiple from 9.1x to 7.8x.
Shared on09 Apr 25Fair value Decreased 2.83%
AnalystConsensusTarget has increased revenue growth from -0.0% to 0.2%.
Shared on02 Apr 25Fair value Decreased 1.06%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Increased 2.00%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.